Immunization Healthcare

The ACIP recommendations for use of Pfizer-BioNTech COVID-19 vaccine in people 16 and older have been updated:

• Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

The following documents have been updated with information about booster doses:

• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine Information Fact Sheet for Recipients and Caregivers
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine Information Fact Sheet for Health Care Personnel 

Instructions have been added on how to access IHD's webinar on the 2021-2022 Northern Hemisphere Influenza Vaccination Program.

The following translated prevaccination checklists have been added under "Forms":

• Prevaccination Checklist for COVID-19 Vaccines (Dari)
• Prevaccination Checklist for COVID-19 Vaccines (Pashto)
• Prevaccination Checklist for COVID-19 Vaccines (English Key)

The following documents have been updated:

• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Moderna COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Janssen (J & J) COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Janssen (J & J) COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

The following documents have been updated:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 13 (Previous versions of this form are obsolete)
• Standing Order for Administering Pfizer-BioNTech COVID-19 Vaccine
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine 
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine Information Fact Sheet for Recipients and Caregivers 
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine Information Fact Sheet for Health Care Personnel 
• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine Storage and Handling Summary 
• Temperature Log for Ultra-Cold Vaccine Storage (Fahrenheit) 
• Temperature Log for Ultra-Cold Vaccine Storage (Celsius) 
• Moderna COVID-19 Vaccine Storage and Handling Summary 
• Janssen (Johnson & Johnson) Vaccine Storage and Handling Summary
• Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary or Off-Site Locations 

The following documents have been updated:

• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Moderna COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel 

The following documents have been updated:

• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States 
• COVID-19 Vaccine Fact Sheet for Preteens and Teens
• Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Summary 
• Moderna COVID-19 Vaccine Beyond Use Date/Time (BUD) Tracking Label for Vaccine During Refrigerator Storage
• Moderna COVID-19 Vaccine Storage and Handling Summary
• Moderna Temperature Log for Frozen Vaccine Storage (Celsius)
• Moderna Temperature Log for Frozen Vaccine Storage (Fahrenheit) 
• Janssen (also known as Johnson & Johnson) COVID-19 Vaccine Storage and Handling Labels

The following documents have been updated:

• DHA Form 177, Potentially Compromised Temperature Sensitive Medical Product Worksheet (CAC authentication required)
• Pfizer-BioNTech Beyond Use Date/Time (BUD) Tracking Label for Vaccine During Refrigerator Storage
• Pfizer-BioNTech Vaccine Storage and Handling Label
• Pfizer-BioNTech Vaccine Storage and Handling Summary
• Moderna Vaccine Storage and Handling Labels
• Moderna Vaccine Storage and Handling Summary
• Janssen (J&J) Vaccine Storage and Handling Summary
• Transporting Janssen (J&J) Vaccine for Vaccination Clinics Held at Satellite, Temporary or Off-Site Locations

The following documents have been updated: 

• Standing Order for Administering Pfizer-BioNTech COVID-19 Vaccine
• Standing Order for Administering Moderna COVID-19 Vaccine
• Janssen (J & J) COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Janssen (J & J) COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

The following documents have been updated:

• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Moderna COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
• Product Information Guide for COVID-19 Vaccines and Associated Products

The DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 11, has been updated with information on co-administration with other vaccines.

The following document has been updated under Vaccine Administration:

• Product Information Guide for COVID-19 Vaccines and Associated Products

The following documents have been updated with new information on Pfizer-BioNTech COVID-19 vaccine:

• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Pfizer-BioNTech Beyond Use Date/Time (BUD) Tracking Label for Vaccine During Refrigerator Storage
• Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Label
• Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Summary
• COVID-19 Vaccine Fact Sheet for Preteens and Teens

The following documents have been updated with information on administering Pfizer-BioNTech COVID-19 vaccine to children and adolescents ages 12 to 15:

• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• Pfizer-BioNTech COVID-19 Vaccine Storage and Handling Label

The following documents have been updated with information on administering Pfizer-BioNTech COVID-19 vaccine to children and adolescents ages 12 to 15:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 10
• Standing Order for Administering Pfizer-BioNTech COVID-19 Vaccine
• Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021 
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers 
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel 
• Pediatric Healthcare Professionals COVID-19 Vaccination Toolkit 
• COVID-19 Vaccine Fact Sheet for Preteens and Teens

The following documents have been updated under Vaccine Storage and Handling Resources:

• Moderna Vaccine Storage and Handling Labels
• Moderna Vaccine Storage and Handling Summary
• Moderna Temperature Log for Frozen Vaccine Storage (Celsius)
• Moderna Temperature Log for Frozen Vaccine Storage (Fahrenheit)
• Janssen (J&J) Vaccine Storage and Handling Summary

The following documents have been updated:

• Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel
• Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
• Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients

• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

The following documents have been updated under Emergency Use Authorization (including Fact Sheets): 

• Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Moderna COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

• Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers

• Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

The following document has been added under "Adverse Events":

• 10 Things Healthcare Providers Need to Know about the Vaccine Adverse Event Reporting System (VAERS)
• How Long-Term Care Facilities Can Help Monitor COVID-19 Vaccine Safety

The following document has been added under "Standing Orders":

• Standing Order for Administering Janssen COVID-19 Vaccine

The following documents have been added for the Janssen (also known as Johnson & Johnson) COVID-19 vaccine under "Vaccine Storage and Handling Resources":

• Vaccine Storage and Handling Labels 
• Vaccine Storage and Handling Summary 

• Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary or Off-Site Locations 

• Temperature Log when Transporting Vaccine at Refrigerated Temperatures 

• Temperature Log for Refrigerator Vaccine Storage (Celsius) 
• Temperature Log for Refrigerator Vaccine Storage (Fahrenheit) 

• Vaccine Storage Troubleshooting Record for Temperature Excursions 

• Vaccine Expiration Date Tracking Tool 

The following document has been updated under "Forms":

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 9

Previous versions of this form are no longer valid and should not be used.

The following document has been updated throughout under "Competency Assessment Checklists":

• Pfizer -80 Vaccine Storage and Handling Competency Assessment

The CDC's Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States has been updated with information on the following:

• Clinical considerations for use of Janssen (also known as Johnson & Johnson) COVID-19 vaccine.
• Recommendations for fully vaccinated people who subsequently develop COVID-19.
• Recommendations related to COVID-19 vaccination timing for immunocompromised people.
• Contraindications and precautions to mRNA COVID-19 vaccines.
• Information on interpretation of SARS-CoV-2 antibody test results after vaccination.

The following recommendations have been added for the Janssen (also known as Johnson & Johnson) COVID-19 vaccine:

• The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

The following document has been updated under Vaccine Administration:

• Product Information Guide for COVID-19 Vaccines and Associated Products

The following documents have been added under "Emergency Use Authorization" following authorization of the Janssen (also known as Johnson & Johnson) COVID-19 vaccine:

• Janssen COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Janssen COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

The following document has been added under Medical Logistics:

• DHA-PI 6205.01: Medical Logistics Guidance for the DOD Coronavirus Disease 2019 (COVID-19) Vaccination Program

The following document has been added under Competency Assessment Checklists:

• Competency Assessment Checklist: Uniformed Support of COVID-19 Vaccinations

The following document has been added under Vaccine Administration:

• Product Information Guide for COVID-19 Vaccines and Associated Products

The CDC's Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States has been updated with information on the following:

• New recommendations for preventing, reporting, and managing vaccine administration errors.
• Clarification on contraindications and precautions.
• Updated information on delayed, local injection-site reactions after the first vaccine dose.
• Updated quarantine recommendations for vaccinated persons.
• Additional information and updated recommendations for testing for TB infection.

The following document has been updated:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 8

Previous versions of this form are no longer valid and should not be used.

The following content has been added under Advisory Committee on Immunization Practices (ACIP) Recommendations:

• Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
• Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine

The following document has been updated to add a link to a storage and handling video:

• Pfizer -80 Vaccine Storage and Handling Competency Assessment

The CDC's Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States has updated its recommendations on the following:

• Intervals between the first and second dose
• Interchangeability of vaccine products
• Vaccination of persons with a history of SARS-CoV-2 infection
• Vaccination of persons with a history of dermal fillers
• Additional resources on vaccine excipients

The following document has been updated:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 7

The following document has been updated:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation, Version 6

The following documents have been updated:

• DHA Form 207, COVID-19 Vaccine Screening and Immunization Documentation
• DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

The following documents have been updated to clarify the number of doses of vaccine per vial after dilution and the instructions for reporting vaccine adverse events:

• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
• Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Health Care Personnel

Information on COVID-19 vaccine has been added in the following categories:

• Vaccine Storage and Handling Resources
• Advisory Committee on Immunization Practices (ACIP) Recommendations

The following documents have been updated to add information on COVID-19 vaccines:

• Vaccines with Diluents: How to use them
• Vaccine Bin Label Examples

Information on the Moderna COVID-19 vaccine has been added in the following categories:

• Standing Orders
• Advisory Committee on Immunization Practices (ACIP) Recommendations

Information on the Moderna COVID-19 vaccine has been added in the following categories:

• Emergency Use Authorization (including Fact Sheets)
• Vaccine Administration
• Vaccine Storage and Handling Resources

COVID-19 vaccine content has been added in the following categories:

• Forms
• Standing Orders
• Emergency Use Authorization (including Fact Sheets)
• Vaccine Administration
• Vaccine Storage and Handling Resources
• Vaccine Ancillary Supply Kit information
• Vaccine Safety
• Advisory Committee on Immunization Practices (ACIP) Recommendations
• Patient Education Resources

The following content from the CDC has been added under "Vaccine Safety":

• v-safe After Vaccination Health Checker Information Sheet
• v-safe After Vaccination Health Checker Poster

IHD COVID-19 Vaccine Resource Center for Health Care Personnel

The following policy document has been posted:

• Coronavirus Disease 2019 Vaccine Guidance (Deputy Secretary of Defense memorandum)

The DHA Education and Training Directorate (J7) is offering Continuing Education/Continuing Medical Education to those who complete the CDC's COVID-19 Vaccine Training. Registration is required. 

The CDC Vaccine Storage and Handling Toolkit has been updated to include information on best practices for storing and handling COVID-19 vaccines.

The Defense Health Agency Immunization Healthcare Division (DHA-IHD) offers two recurring in-person and virtual training opportunities: the two-day Immunization Lifelong Learners Course (ILLC) and the one-day Immunization Lifelong Learners Short Course (ILLSC). Individual courses will be announced here when they are opened for registration. These courses are designed to ensure health care personnel are trained in vaccine policy, vaccine safety, and effectiveness based on national and DOD guidelines.

Continuing education will be available for these activities. See our Immunization Lifelong Learners Course or Short Course pages for more details and for listings of each course.